Please use this identifier to cite or link to this item:
|Title:||Design and Syntheses of Highly Potent Teixobactin Analogues against Staphylococcus aureus, Methicillin-Resistant Staphylococcus aureus (MRSA), and Vancomycin-Resistant Enterococci (VRE) in Vitro and in Vivo||Authors:||Parmar, Anish
Goh, Eunice Tze Leng
Lloyd, Daniel G.
Chalasani, Madhavi Latha Somaraju
Verma, Navin Kumar
Prior, Stephen H.
Beuerman, Roger W.
Taylor, Edward J.
|Issue Date:||2018||Source:||Parmar, A., Lakshminarayanan, R., Iyer, A., Mayandi, V., Goh, E. T. L., Lloyd, D. G., et al. (2018). Design and Syntheses of Highly Potent Teixobactin Analogues against Staphylococcus aureus, Methicillin-Resistant Staphylococcus aureus (MRSA), and Vancomycin-Resistant Enterococci (VRE) in Vitro and in Vivo. Journal of Medicinal Chemistry, 61(5), 2009-2017.||Series/Report no.:||Journal of Medicinal Chemistry||Abstract:||The cyclic depsipeptide, teixobactin, kills a number of Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA), and Mycobacterium tuberculosis without detectable resistance. To date, teixobactin is the only molecule in its class that has shown in vivo antibacterial efficacy. In this work, we designed and synthesized 10 new in vivo ready teixobactin analogues. These analogues showed highly potent antibacterial activities against Staphylococcus aureus, MRSA, and vancomycin-resistant enterococci (VRE) in vitro. One analogue, d-Arg4-Leu10-teixobactin, 2, was found to be noncytotoxic in vitro and in vivo. Moreover, topical instillation of peptide 2 in a mouse model of S. aureus keratitis decreased the bacterial bioburden (>99.0% reduction) and corneal edema significantly as compared to untreated mouse corneas. Collectively, our results have established the high therapeutic potential of a teixobactin analogue in attenuating bacterial infections and associated severities in vivo.||URI:||https://hdl.handle.net/10356/88754
|ISSN:||0022-2623||DOI:||10.1021/acs.jmedchem.7b01634||Rights:||© 2018 American Chemical Society. This is the author created version of a work that has been peer reviewed and accepted for publication by Journal of Medicinal Chemistry, American Chemical Society. It incorporates referee’s comments but changes resulting from the publishing process, such as copyediting, structural formatting, may not be reflected in this document. The published version is available at: [http://dx.doi.org/10.1021/acs.jmedchem.7b01634].||Fulltext Permission:||open||Fulltext Availability:||With Fulltext|
|Appears in Collections:||LKCMedicine Journal Articles|
Files in This Item:
|Design and syntheses of highly potent teixobactin analogues against Staphylococcus aureus.pdf||804.48 kB||Adobe PDF|
Updated on Mar 8, 2021
Updated on Mar 9, 2021
Updated on Dec 7, 2021
Updated on Dec 7, 2021
Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.